The pre-surgical factors that determine the decision to proceed to resection in children diagnosed with high-risk neuroblastoma in a resource limited setting

被引:0
作者
van Heerden, Jaques [1 ,2 ,3 ]
Kruger, Mariana [1 ]
Esterhuizen, Tonya Marianne [4 ]
van Zyl, Anel [1 ]
Hendricks, Marc [5 ,6 ]
Cox, Sharon [7 ]
Mangray, Hansraj [8 ]
Poole, Janet [9 ]
Naidu, Gita [10 ]
Buchner, Ane [11 ]
de Villiers, Mariza [12 ]
du Plessis, Jan [13 ]
van Emmenes, Barry [14 ]
Matthews, Elmarie [15 ]
Manickchund, Yashoda [16 ]
Harrison, Derek Stanley [17 ]
机构
[1] Stellenbosch Univ, Tygerberg Hosp, Fac Med & Hlth Sci, Dept Paediat & Child Hlth,Paediat Haematol & Onco, Cape Town, South Africa
[2] Antwerp Univ Hosp, Dept Paediat, Paediat Haematol & Oncol, Antwerp, Belgium
[3] Univ Antwerp, Dept Med Mol Imaging Pathol Radiotherapy & Oncol, Antwerp, Belgium
[4] Stellenbosch Univ, Fac Med & Hlth Sci, Div Epidemiol & Biostat, Stellenbosch, South Africa
[5] Univ Cape Town, Fac Hlth Sci, Dept Paediat & Child Hlth, Cape Town, South Africa
[6] Red Cross War Mem Childrens Hosp, Paediat Haematol & Oncol Serv, Cape Town, South Africa
[7] Univ Cape Town, Red Cross War Mem Childrens Hosp, Div Paediat Surg, Cape Town, South Africa
[8] Univ KwaZulu Natal, Greys Hosp, Dept Paediat Surg, Pietermaritzburg, South Africa
[9] Univ Witwatersrand, Charlotte Maxeke Johannesburg Acad Hosp, Fac Hlth Sci, Dept Paediat & Child Hlth, Johannesburg, South Africa
[10] Univ Witwatersrand, Chris Hani Baragwanath Acad Hosp, Fac Hlth Sci, Dept Paediat & Child Hlth, Johannesburg, South Africa
[11] Univ Pretoria, Steve Biko Acad Hosp, Dept Paediat, Paediat Haematol & Oncol, Pretoria, South Africa
[12] Univ Pretoria, Steve Biko Acad Hosp, Dept Paediat Surg, Pretoria, South Africa
[13] Univ Free State, Univ Hosp, Dept Paediat Fac Hlth Sci, Div Paediat Haematol & Oncol, Bloemfontein, South Africa
[14] Walter Sisulu Univ, Div Paediat Haematol & Oncol Hosp, Dept Paediat, Mthatha, South Africa
[15] Walter Sisulu Univ, Port Elizabeth Prov Hosp, Dept Paediat & Child Hlth, Paediat Haematol Oncol, Port Elizabeth, South Africa
[16] Walter Sisulu Univ, Dept Paediat Surg, East London, South Africa
[17] Univ Witwatersrand, Chris Hani Baragwanath Acad Hosp, Fac Hlth Sci, Dept Paediat Surg, Johannesburg, South Africa
关键词
High-risk; image defined risk factors; neuroblastoma; predicting surgery; remission; South Africa; STAGE; 4; NEUROBLASTOMA; SURGICAL RESECTION; SURVIVAL; SURGERY;
D O I
10.1080/08880018.2022.2137610
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Surgical control has prognostic value in neuroblastoma (NB). Advanced NB is common at diagnosis in South Africa. We investigated the pre-surgery factors that influenced decisions to perform surgical resections. We included 204 patients with high-risk NB from a national retrospective study, who completed induction chemotherapy between 2000 and 2016. The median age was 32.4 months (IQR 15.1 - 53.5 months). Primary tumor resection was achieved in 76.9% of patients between 0-18 months of age, 51.8% between 18-60 months and 51.7% older than 60 months (p < 0.001). Only 43.2% of patients with distant metastatic disease had surgery done (p < 0.001). LDH was >750 U/L in 46.8% and ferritin >120 g/dL in 53.1% of those who had surgery (p = 0.005). The majority (80.4%), who had achieved post-induction metastatic complete remission (mCR), were operated, while 28.7% without mCR had surgery (p < 0.001). The long-term overall survival in patients with mCR and primary tumor resection was 36.5% compared to those with mCR without primary tumor resection (25.4%) and without mCR (<= 3.0%)(p < 0.001). Age (p < 0.001), stage (p < 0.001), mCR (p < 0.001) and treatment setting (p < 0.001) were of prognostic significance. The tumor site and MYCN-amplification did not significantly predict resection rates. Post-induction mCR and stage were associated with surgical resection and five-year OS (p < 0.001) on multivariate analysis. Patients with high-risk NB who achieved mCR and had primary tumor resections are curable in limited resourced settings. Stage and post-induction mCR were significant variables that led to surgery. These variables should be included as indications in the management of metastatic NB in resource limited settings. TEACHING POINTS center dot High-risk neuroblastoma that achieved post-induction chemotherapy metastatic remission and have undergone resection, is curable, even in limited resource settings. center dot Achieving metastatic complete remission was the only factor that significantly predicated if surgery was done. center dot The age at diagnosis, stage and hospitals with expertise in neuroblastoma surgery were of prognostic significance in South Africa. center dot If a patient with high-risk neuroblastoma achieves metastatic complete remission in a resource limited setting, it should be an indication for resection of the primary tumor.
引用
收藏
页码:242 / 257
页数:16
相关论文
共 27 条
  • [1] Treatment of high-risk neuroblastoma: National protocol results of the Turkish Pediatric Oncology Group
    Aksoylar, Serap
    Varan, Ali
    Vergin, Canan
    Hazar, Volkan
    Akici, Ferhan
    Dagdemir, Ayhan
    Buyukavci, Mustafa
    Kebudi, Rejin
    Kurucu, Nilgun
    Sevinir, Betul
    Unal, Emel
    Vural, Sema
    Guler, Elif
    Apak, Hilmi
    Oniz, Haldun
    Karadeniz, Ceyda
    Canpolat, Cengiz
    Anak, Sema
    Ilhan, Inci
    Ince, Dilek
    Cecen, Emre
    Olgun, Nur
    [J]. JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2017, 13 (02) : 284 - 290
  • [2] Image-defined risk factors in unresectable neuroblastoma: SIOPEN study on incidence, chemotherapy-induced variation, and impact on surgical outcomes
    Avanzini, Stefano
    Pio, Luca
    Erminio, Giovanni
    Granata, Claudio
    Holmes, Keith
    Gambart, Marion
    Buffa, Piero
    Castel, Victoria
    Couanet, Dominique Valteau
    Garaventa, Alberto
    Pistorio, Angela
    Cecchetto, Giovanni
    Martucciello, Giuseppe
    Mattioli, Girolamo
    Sarnacki, Sabine
    [J]. PEDIATRIC BLOOD & CANCER, 2017, 64 (11)
  • [3] Incidence, Survival, and Treatment of Localized and Metastatic Neuroblastoma in Germany 1979-2015
    Berthold, Frank
    Spix, Claudia
    Kaatsch, Peter
    Lampert, Fritz
    [J]. PEDIATRIC DRUGS, 2017, 19 (06) : 577 - 593
  • [4] Guidelines for Imaging and Staging of Neuroblastic Tumors: Consensus Report from the International Neuroblastoma Risk Group Project
    Brisse, Herve J.
    McCarville, M. Beth
    Granata, Claudio
    Krug, K. Barbara
    Wootton-Gorges, Sandra L.
    Kanegawa, Kimio
    Giammarile, Francesco
    Schmidt, Matthias
    Shulkin, Barry L.
    Matthay, Katherine K.
    Lewington, Valerie J.
    Sarnacki, Sabine
    Hero, Barbara
    Kaneko, Michio
    London, Wendy B.
    Pearson, Andrew D. J.
    Cohn, Susan L.
    Monclair, Tom
    [J]. RADIOLOGY, 2011, 261 (01) : 243 - 257
  • [5] Clinical prognostic factors in 1277 patients with neuroblastoma: results of The European Neuroblastoma Study Group 'Survey' 1982-1992
    Cotterill, SJ
    Pearson, ADJ
    Pritchard, J
    Foot, ABM
    Roald, B
    Kohler, JA
    Imeson, J
    [J]. EUROPEAN JOURNAL OF CANCER, 2000, 36 (07) : 901 - 908
  • [6] Local control in metastatic neuroblastoma in children over 1 year of age
    De Ioris, Maria Antonietta
    Crocoli, Alessandro
    Contoli, Benedetta
    Garganese, Maria Carmen
    Natali, Gianluigi
    Toma, Paolo
    Jenkner, Alessandro
    Boldrini, Renata
    De Pasquale, Maria Debora
    Milano, Giuseppe Maria
    Madafferi, Silvia
    Castellano, Aurora
    Locatelli, Franco
    Inserra, Alessandro
    [J]. BMC CANCER, 2015, 15
  • [7] Role of surgery in the treatment of patients with high-risk neuroblastoma who have a poor response to induction chemotherapy
    Du, Lei
    Liu, Ling
    Zhang, Chi
    Cai, Wei
    Wu, Yeming
    Wang, Jun
    Lv, Fan
    [J]. JOURNAL OF PEDIATRIC SURGERY, 2014, 49 (04) : 528 - 533
  • [8] High-risk neuroblastoma in a sub-Saharan African country: telling it like it is
    Hadley, G. P.
    van Heerden, J.
    [J]. TROPICAL DOCTOR, 2017, 47 (04) : 370 - 374
  • [9] Localized infant neuroblastomas often show spontaneous regression: Results of the prospective trials NB95-S and NB97
    Hero, Barbara
    Simon, Thorsten
    Spitz, Ruediger
    Ernestus, Karen
    Gnekow, Astrid K.
    Scheel-Walter, Hans-Guenther
    Schwabe, Dirk
    Schilling, Freimut H.
    Benz-Bohm, Gabriele
    Berthold, Frank
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (09) : 1504 - 1510
  • [10] Influence of Surgical Excision on the Survival of Patients With Stage 4 High-Risk Neuroblastoma: A Report From the HR-NBL1/SIOPEN Study
    Holmes, Keith
    Poetschger, Ulrike
    Pearson, Andrew D. J.
    Sarnacki, Sabine
    Cecchetto, Giovanni
    Gomez-Chacon, Javier
    Squire, Roly
    Freud, Enrique
    Bysiek, Adam
    Matthyssens, Lucas E.
    Metzelder, Martin
    Monclair, Tom
    Stenman, Jakob
    Rygl, Michal
    Rasmussen, Lars
    Joseph, Jean-Marc
    Irtan, Sabine
    Avanzini, Stefano
    Godzinski, Jan
    Bjornland, Kristin
    Elliott, Martin
    Luksch, Roberto
    Castel, Victoria
    Ash, Shifra
    Balwierz, Walentyna
    Laureys, Genevieve
    Ruud, Ellen
    Papadakis, Vassilios
    Malis, Josef
    Owens, Cormac
    Schroeder, Henrik
    Beck-Popovic, Maja
    Trahair, Toby
    de Lacerda, Ana Forjaz
    Ambros, Peter F.
    Gaze, Mark N.
    McHugh, Kieran
    Valteau-Couanet, Dominique
    Ladenstein, Ruth Lydia
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (25) : 2902 - +